Dec 11, 2024
1:10
For every 10 shares held, investors received 1.
The split itself did not change the total investment value.
Vesalius Longevity Labs Inc. (CSE:VLAB) operates in the Pharmaceuticals: other industry.
Vesalius Longevity Labs Inc. company overviewVesalius Longevity Labs Inc.'s most recent stock split was on December 11, 2024. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Vesalius Longevity Labs Inc. (CSE:VLAB) has split its stock 3 times: a 1-for-5 reverse split on June 20, 2022, a 1-for-8 reverse split on May 2, 2023, and a 1-for-10 reverse split on December 11, 2024.
Vesalius Longevity Labs Inc. has split its stock 3 times. This history records 3 reverse splits between June 20, 2022 and December 11, 2024.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Vesalius Longevity Labs Inc.'s 1-for-10 reverse split on December 11, 2024, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Vesalius Longevity Labs Inc. has not announced a new split in our records. Its most recent split was on December 11, 2024, 1 year ago. Companies announce splits in advance, and any new CSE:VLAB split will appear on this page.